Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
COLO 858 | Vemurafenib | PF562271 | 0.100 | 3.160 | uM | 72 | hr | 1 | 912 | 724 | 0.0339 | 0.0290 | 0.7939 | 0.7843 |
A-375 | Vemurafenib | Dasatinib | 0.316 | 1.000 | uM | 72 | hr | 1 | 1292 | 66 | 0.0621 | 0.0577 | 0.0511 | 0.0487 |
WM-115 | Vemurafenib | JNK-IN-8 | 3.160 | 0.316 | uM | 72 | hr | 1 | 1731 | 422 | 0.3311 | 0.3217 | 0.2438 | 0.2378 |
COLO 858 | Vemurafenib | PF562271 | 0.316 | 0.000 | uM | 72 | hr | 1 | 1748 | 230 | 0.2738 | 0.2879 | 0.1316 | 0.1549 |
A-375 | Vemurafenib | Saracatinib | 0.100 | 0.000 | uM | 72 | hr | 1 | 9635 | 173 | 0.4953 | 0.4364 | 0.0180 | 0.0207 |
A-375 | Vemurafenib | Belinostat | 0.100 | 0.000 | uM | 72 | hr | 1 | 6493 | 153 | 0.4841 | 0.4690 | 0.0236 | 0.0238 |
COLO 858 | Vemurafenib | PF562271 | 0.316 | 0.316 | uM | 72 | hr | 1 | 1301 | 460 | 0.1517 | 0.1439 | 0.3536 | 0.3763 |
A-375 | Vemurafenib | JNK-IN-8 | 0.000 | 1.000 | uM | 72 | hr | 1 | 11677 | 368 | 0.7113 | 0.6866 | 0.0315 | 0.0312 |
A-375 | Vemurafenib | Belinostat | 0.316 | 1.000 | uM | 72 | hr | 1 | 1495 | 539 | 0.0730 | 0.0676 | 0.3605 | 0.4031 |
COLO 858 | Vemurafenib | PF562271 | 0.316 | 1.000 | uM | 72 | hr | 1 | 1035 | 564 | 0.0849 | 0.0793 | 0.5449 | 0.5384 |
A-375 | Vemurafenib | Saracatinib | 0.100 | 0.316 | uM | 72 | hr | 1 | 5747 | 125 | 0.2943 | 0.3050 | 0.0218 | 0.0212 |
COLO 858 | Vemurafenib | PF562271 | 1.000 | 3.160 | uM | 72 | hr | 1 | 595 | 559 | 0.0065 | 0.0058 | 0.9395 | 0.9416 |
COLO 858 | Vemurafenib | PF562271 | 0.316 | 3.160 | uM | 72 | hr | 1 | 526 | 473 | 0.0096 | 0.0109 | 0.8992 | 0.8930 |
A-375 | Vemurafenib | Defactinib | 0.000 | 0.316 | uM | 72 | hr | 1 | 16963 | 834 | 0.7730 | 0.8197 | 0.0492 | 0.0506 |
COLO 858 | Vemurafenib | PF562271 | 3.160 | 0.000 | uM | 72 | hr | 1 | 1042 | 801 | 0.0435 | 0.0334 | 0.7687 | 0.8371 |
COLO 858 | Vemurafenib | PF562271 | 1.000 | 0.000 | uM | 72 | hr | 1 | 1250 | 489 | 0.1372 | 0.1377 | 0.3912 | 0.4424 |
A-375 | Vemurafenib | Saracatinib | 0.100 | 1.000 | uM | 72 | hr | 1 | 4016 | 78 | 0.2061 | 0.2010 | 0.0194 | 0.0218 |
A-375 | Vemurafenib | Dasatinib | 0.100 | 0.316 | uM | 72 | hr | 1 | 3389 | 65 | 0.1683 | 0.1709 | 0.0192 | 0.0246 |
COLO 858 | Vemurafenib | PF562271 | 1.000 | 0.316 | uM | 72 | hr | 1 | 1154 | 797 | 0.0644 | 0.0514 | 0.6906 | 0.7028 |
A-375 | Vemurafenib | JNK-IN-8 | 0.000 | 3.160 | uM | 72 | hr | 1 | 5745 | 285 | 0.3434 | 0.2974 | 0.0496 | 0.0491 |
COLO 858 | Vemurafenib | PF562271 | 3.160 | 1.000 | uM | 72 | hr | 1 | 1199 | 1142 | 0.0103 | 0.0092 | 0.9525 | 0.9423 |
COLO 858 | Vemurafenib | PF562271 | 1.000 | 1.000 | uM | 72 | hr | 1 | 942 | 775 | 0.0301 | 0.0248 | 0.8227 | 0.8407 |
A-375 | Vemurafenib | Saracatinib | 0.100 | 3.160 | uM | 72 | hr | 1 | 3954 | 69 | 0.2034 | 0.1687 | 0.0175 | 0.0176 |
A-375 | Vemurafenib | I-BET | 0.316 | 0.000 | uM | 72 | hr | 1 | 4169 | 116 | 0.2972 | 0.2900 | 0.0278 | 0.0255 |
A-375 | Vemurafenib | I-BET | 0.100 | 1.000 | uM | 72 | hr | 1 | 4909 | 225 | 0.3435 | 0.3080 | 0.0458 | 0.0484 |